Finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease: a randomized placebo-controlled mechanistic trial (FIVE-STAR)

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Late-breaking clinical trials in chronic heart failure Aldosterone Antagonists HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by